Observations on the recent crackdown on medical corruption by the Central Commission for Discipline Inspection

Background Introduction#

The Central Commission for Discipline Inspection and the National Supervisory Commission have recently deployed a concentrated rectification campaign on corruption issues in the national pharmaceutical field, aiming to deepen the treatment of both symptoms and root causes, and promote the prevention of corruption. The rectification campaign covers the entire pharmaceutical field, the entire chain, and the entire scope, with a focus on key areas such as pharmaceutical production, supply, sales, use, reimbursement, etc., and "key few" individuals. It insists on investigating both bribery and corruption, forming a deterrent effect.

According to reports, corruption in the medical field presents characteristics such as concealment, diversity, and complexity. For example, some pharmaceutical companies engage in illegal interest transfers through sponsorship of research funds, academic conference fees, etc.; some give kickbacks to hospital staff in the pharmaceutical procurement and sales process; some embezzle funds through methods such as inflating drug prices in the production process and false transactions in the circulation process.

In order to precisely punish these new types of corruption and hidden corruption, the Central Commission for Discipline Inspection and the National Supervisory Commission have taken various measures, such as implementing "small incision" breakthroughs, targeted investigations, discovering problem clues, and conducting in-depth investigations into concealed interest transfers; increasing the intensity of disciplinary and law enforcement, focusing on leading cadres and key positions, and concentrating efforts to investigate a batch of corruption cases in the pharmaceutical field; cooperating with the deliberation of the draft amendment to the Criminal Law (Twelfth), increasing the penalty levels for corporate bribery crimes, and standardizing the differentiation and sentencing of bribery crimes.

The Current Situation and Harm of Medical Corruption#

Causes and Characteristics of Medical Corruption#

Evaluation#

Lack of public supervision#

Hypocritical rule of law#

Achievements cannot benefit the entire population#

Limitations of the capitalist system#

Suggestions and Prospects - Fantasy Time#

(1) Deeply Focus on and Strictly Investigate the Concealed Interest Transfers in the Medical Field - Headlines - Central Commission for Discipline Inspection and National Supervisory Commission Website. https://www.ccdi.gov.cn/toutiaon/202302/t20230206_244791.html

(2) The Central Commission for Discipline Inspection and the National Supervisory Commission Target "Corporate Bribery" to Precisely Punish Key Areas in the Medical and Health Field
https://finance.ifeng.com/c/8S5hcU0gOPB

(3) Severing the Corruption Interest Chain in the Medical Field - Central Commission for Discipline Inspection and National Supervisory Commission Website
https://www.ccdi.gov.cn/yaowen/202106/t20210607_243354.html